January 18, 2026

growth stocks

2 Artificial Intelligence (AI) Stocks to Buy With $200 Right Now and Hold for Decades

1. Nvidia (NVDA) 2. Microsoft (MSFT) Hold for decades

The rise of AI is creating opportunities for long-term wealth creation. One way to invest in this technology is through AI stocks. Here are two such stocks that are worth considering for a long-term portfolio:

1. C3.ai (AI): This company provides AI software for various applications, including predictive modeling and process optimization.
2. Palantir Technologies (PLTR): This company offers data analytics platforms for defense, intelligence, and commercial organizations.

These companies are poised to benefit from the increasing demand for AI solutions across industries. While their stocks may fluctuate in the short term, holding them for decades could yield significant returns as AI continues to transform businesses and societies. With a modest investment of $200 in each stock, investors can gain exposure to this transformative technology.

Read More
History Says the Nasdaq Will Soar in 2024: Here Are My Top 5 Software Growth Stocks to Buy Before It Does

History Says the Nasdaq Will Soar in 2024: Here Are My Top 5 Software Growth Stocks to Buy Before It Does

Amidst market uncertainty, history presents a positive outlook for the Nasdaq in 2024. As we approach this potential surge, discerning investors are seeking high-growth software stocks poised to capitalize on this trend. Here, we present our top 5 picks with a proven track record of innovation and customer acquisition. Each selection aligns with the projected resurgence of the Nasdaq, providing investors with a unique opportunity to ride the wave of anticipated growth.

Read More
3 Biotech Titans: Invest Now, Reap Rewards for a Decade

3 Biotech Titans: Invest Now, Reap Rewards for a Decade

In the dynamic world of biotechnology, long-term investments can reap significant rewards. As we look towards the next decade, we’ve identified three biotech stocks that stand out as compelling buy-and-hold opportunities. These companies are poised to revolutionize healthcare with cutting-edge therapies, innovative technologies, and a strong commitment to improving lives. From gene editing to protein engineering, these stocks offer investors the potential for substantial growth and a positive impact on the world.

Read More